# Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance

> **NCT05136963** · PHASE1 · UNKNOWN · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 48 (estimated)

## Conditions studied

- Kidney Function Test

## Interventions

- **DRUG:** Iohexol
- **BIOLOGICAL:** pharmacokinetics

## Key facts

- **NCT ID:** NCT05136963
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-06
- **Primary completion:** 2025-04
- **Final completion:** 2025-04
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05136963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05136963, "Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05136963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*